Relationship between endothelin-1 levels and pulmonary arterial hypertension in HIV-infected patients

AIDS

Volumn 28, Issue 18, 2014, Pages 2693-2699

  Feijoo, Maribel Q ^a   Toro, Rocío ^b   De La Torre, Mariola López Vazquez ^a   Lennie, Vera ^a   Arce, Cristina ^a   Moreno, Victoria ^a   Valencia, Eulalia ^a   Vispo, Eugenia ^a   Almería, Carlos ^c   Mangas, Alipio ^b   Carbonero, Luz M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Department of Medicine School of Medicine ^*  (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Coinfection with hepatitis C virus; Endothelial dysfunction; Endothelin 1; HIV infection; Pulmonary arterial hypertension

Indexed keywords

ENDOTHELIN 1; BIOLOGICAL MARKER;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIN 1 BLOOD LEVEL; FEMALE; HIGH RISK POPULATION; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORMAL VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RISK FACTOR; SEX; VIRUS LOAD; BLOOD; COMPLICATION; HYPERTENSION, PULMONARY; PATHOLOGY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENDOTHELIN-1; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED;

EID: 84927731512     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000470     Document Type: Article

References (36)

1. Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, et al. HIV and coronary heart disease: Time for a better understanding. J Am Coll Cardiol 2013; 61:511-523.
2. Nunes H, Humbert M, Sitbon O, Morse JH, Deng Z, Knowles JA, et al. Prognostic factors for survival in human immunodeficiency virus-associated primary pulmonary hypertension. Am J Respir Critic Care Med 2003; 167:1433-1439.
3. Quezada M, Martin-Carbonero L, Soriano V, Vispo E, Valencia E, Moreno V, et al. Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up. AIDS 2012; 26:1387-1392.
4. Dupuis J. Endothelin: Setting the scene in PAH. Eur Respir Rev 2007; 16:1023-7.
5. El Chami H, Hassoun P. Immune and inflammatory mechanisms in pulmonary arterial hypertension. Prog Cardiovasc Dis 2012; 55:218-228.
6. Humbert M. Mediators involved in HIV-related pulmonary arterial hypertension. AIDS 2008; 3:S41-S47.
7. Almodovar S, Knight R, Allshouse AA, Roemer S, Lozupone C, McDonald D, et al. Human inmunodeficiency virus nef signature sequences are associated with pulmonary hypertension. AIDS Res Hum Retroviruses 2012; 28:607-618.
8. Sherman KE, Shire NJ, Rouster SD, Peters MG, James Koziel M, Chung RT, et al. Hepatitis C prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US Adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34:831-837.
9. Montani D, Marcelin AG, Sitbon O, Calvez V, Simonneau G, Humbert M, et al. Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in France. AIDS 2005; 19:1239-1240.
10. De Cool C, Voelkel N, Todd B. Viral infection and pulmonary hypertension: is there an association? Expert Rev Resp Med 2011; 5:207-216.
11. Fagan K, McMurtry I, Rodman D. Role of endothelin-1 lung disease. Respi Res 2001; 2:90-101.
12. Von Lueder TG, Kjekshus H, Edvardsen T, ØIe E, Urheim S, Vinge LE, et al. Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1. Cardiovasc Res 2004; 63:41-50.
13. Staniloae C, Dupuis J, White M, Gosselin G, Dyrda I, Bois M, et al. Reduced pulmonary clearance of endothelin in congestive heart failure: A marker of secondary pulmonary hypertension. J Card Fail 2004; 10:427-432.
14. Thorin E, Clozel M. The cardiovascular physiology and pharmacology of endothelin-1. Adv Pharmacol 2010; 60: 1-26.
15. Lerman A, Kubo SH, Tschumperlin LK, Burnett JC Jr. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol 1992; 20:849-853.
16. Langleben D, Dupuis J, Langleben I, Hirsch A, Baron M, Senécal JL, et al. Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension. Chest 2006; 129:689- 695.
17. Horton KD, Meece RW, Hill JS. Assessment of the right ventricle by echocardiography: A primer for cardiac sonographers. J Am Soc Echocardiogr 2009; 22:776-792.
18. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23:685- 713.
19. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54:S55- S56.
20. Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ. A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 2003; 41:1021-1027.
21. Bauer M, Wilkens H, Langer F, Schneider SO, Lausberg H, Schafers HJ. Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation 2002; 105:1034-1036.
22. Mette SA, Palevsky HI, Pietra GG, Williams TM, Bruder E, Prestipino AJ, et al. Primary pulmonary hypertension in association with human immunodeficiency virus infection. Am Rev Respir Dis 1992; 145:1196-1200.
23. Lederman MM, Sereni D, Simonneau G, Voelkel NF. Pulmonary arterial hypertension and its association with HIV infection: An overview. AIDS 2008; 3:S1-S6.
24. Kanmogne GD, Primeaux CH, Grammas P. Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins. Biochem Biophys Res Commun 2005; 333:1107-1115.
25. Ehrenreich H, Rieckmann P, Sinowatz F, Weih KA, Arthur LO, Goebel FD, et al. Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J Immunol 1993; 150:4601-4609.
26. Fiala M, Popik W, Qiao JH, Lossinsky AS, Alce T, Tran K, et al. HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, Tat and cytokine apopotic signaling. Cardiovasc Toxicol 2004; 4:97-107.
27. Hebert VY, Crenshaw BL, Romanoff RL, Ekshyyan VP, Dugas TR. Effects of HIV drug combinations on endothelin-1 and vascular cell proliferation. Cardiovasc Toxicol 2004; 4:117- 131.
28. Dhillon NK, Li F, Xue B, Tawfik O, Morgello S, Busch S, et al. Effect of cocaine on human immunodeficiency virus-mediated pulmonary endothelial and smooth muscle dysfunction. Am J Respir Cell Mol Bio 2011; 45:40- 52.
29. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 1991; 84:2280- 2285.
30. Montani D, Souza R, Binkert CH, Fischli W, Simonneau G, Clozel M, et al. Endothelin-1/endothelin-3 ratio: A potential prognosis factor of pulmonary arterial hypertension. Chest 2007; 131:101-108.
31. Pol S, Soriano V. Management of chronic hepatitis C virus infection in HIV-infected patients. Clin Infect Dis 2008; 47:94-101.
32. Guiltinan AM, Kaidorova Z, Custer B, Orland J, Strollo A, Cyrus S, et al. Increased all-cause, liver, and cardiac mortality among hepatitis C virus seropositive blood donors. Am J Epidemiol 2008; 167:743-750.
33. Pérez-Latorre L, Sánchez-Conde M, Rincón D, Miralles P, Aldámiz-Echevarría T, Carrero A, et al. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography. Clin Infect Dis 2014; 58:713-718.
34. de Castro IF, Micheloud D, Berenguer J, Guzmán-Fulgencio M, Catalán P, Miralles P, et al. Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients. AIDS 2010; 24:2059-2067.
35. Notas G, Xidakis G, Valatas V, Kouroumalis A, Kouromalis E. Levels of circulating endothelin-1 and nitrates/nitrates in patients with virus-related hepatocellular carcinoma. J Viral Hepat 2001; 8:63-69.
36. Isobe H, Satoh M, Sakai H, Nawata H. Increased plasma endothelin-1 levels in patients with cirrhosis and esophageal varices. J Clin Gastroenterol 1993; 17:227-230.